The Honourable Marjorie Michel, Minister of Health, will make an important announcement on helping to address the substance use and overdose crisis in the Atlantic Region.
Today, the Minister of Health, Marjorie Michel, launched a 45-day public consultation on proposed changes to how Canada regulates precursor chemicals and devices such as pill presses and encapsulators that could be used in the illegal production of drugs. The consultation is open until August 12, 2025.
Today, the Honourable Kamal Khera, Minister of Health, accompanied by the Honourable Ali Ehsassi, Minister of Government Transformation, Public Services and Procurement announced that all remaining eligible Canadians aged 18 to 64 years-old will be able to apply for the CDCP in May 2025; with coverage starting as early as June 1, 2025.
Today, the Honourable Kamal Khera, Canada’s Minister of Health, announced an agreement with Quebec investing over $305 million to support access to new and existing drugs, early diagnosis, and screening for rare diseases and Quebec’s Action Plan on Rare Diseases 2023-2027.
Today, the Honourable Kamal Khera, Canada’s Minister of Health, and the Honourable Michelle Thompson, Nova Scotia’s Minister of Health and Wellness, announced a bilateral agreement investing over $39 million to improve access to selected new drugs for rare diseases, and to support enhanced access to existing drugs, early diagnosis, and screening.
Today, the Governments of Canada and Nova Scotia signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $39 million over three years to improve access to new drugs for rare diseases for Nova Scotia residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.
Today, Member of Parliament Brendan Hanley, on behalf of the Honourable Kamal Khera, Canada’s Minister of Health, and the Honourable Tracy-Anne McPhee, Yukon’s Minister of Health and Social Services, announced the signing of a pharmacare agreement to invest up to $9.5 million over four years to provide universal access to contraceptive and diabetes medications for residents of Yukon. The funding from this agreement will also improve access to diabetes devices and supplies.
Today, the Government of Canada and the territory of Yukon signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $8.5 million over three years to improve access to new drugs for rare diseases for residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.
Today, the Governments of Canada and Northwest Territories signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $7.8 million over three years to improve access to new drugs for rare diseases for residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases.